Drugs Made In America Acquisition Corp.
DMAA
$10.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 2.29M | 1.25M | -279.90K | -- | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -2.43M | -1.49M | 31.60K | -- | |
| Change in Net Operating Assets | 36.20K | -14.90K | 125.10K | -- | |
| Cash from Operations | -106.70K | -251.20K | -123.20K | -- | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 0.00 | -231.15M | -- | -- | |
| Cash from Investing | 0.00 | -231.15M | -- | -- | |
| Total Debt Issued | -- | -- | 1.39M | -- | |
| Total Debt Repaid | 0.00 | -900.00K | -1.03M | -- | |
| Issuance of Common Stock | 106.60K | 232.30M | 25.00K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 0.00 | 3.20K | -260.40K | -- | |
| Cash from Financing | 106.60K | 231.40M | 123.40K | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -100.00 | -400.00 | 200.00 | -- | |